Skip to main content
. 2016 Mar 30;7(18):26293–26306. doi: 10.18632/oncotarget.8477

Table 1. Predicted impact of APE1 variants on protein structure/function.

APE1genetic variants Source Percentageoffrequency Functionalconsequences PROVEAN SIFT CUPSAT PolyPhen-2
Score Prediction Score Prediction Overallstability Torsion Score Prediction
L104R ALS once Reduced AP endonuclease activity (~40%)[9].Impaired 3′-RNA phosphatase and endoribonuclease activities [15, 20] −4.925 Deleterious 0.00 Affectedproteinfunction Stabilizing Unfavorable 0.987 Probably damaging
D148E NCBI rs1130408 48.5 Normal AP endonuclease activity [8, 9]. Impaired 3′-RNA phosphatase and endoribonuclease activities [15, 20] −0.204 Neutral 1.00 Tolerated Destabilizing Favorable 0.000 Benign
R237C Tumor, NCBI rs375526265 once Reduced 3′ to5′ exonuclease and 3′-damage excision activities; slightly reduced AP-DNA complex stability [8].Reduced incision capacity in proximity of nucleosomes [21] −7.884 Deleterious 0.00 Affected protein function Stabilizing Unfavorable 1.000 Probably damaging
D283G ALS once Reduced AP endonuclease activity (~90%) [9] −6.910 Deleterious 0.00 Affected protein function Destabilizing Unfavorable 1.000 Probably damaging

For PROVEAN software (http://provean.jcvi.org/index.php), a cut-off score ≤ −2.5 is considered as deleterious, while a value greater than that is predicted as neutral. For SIFT modelling software (http://sift.jcvi.org/), a score ≤ 0.05 is considered as deleterious, whereas > 0.05 is predicted as tolerated. As template, the APE1 sequence (NP_001632.2) was used. For the PolyPhen-2 tool (http://genetics.bwh.harvard.edu/pph2/) and PROVEAN model, APE1 UniProtKB sequence (P27695) was used as query. CUPSAT predictions (http://cupsat.tu-bs.de/) were obtained by using the PDB APE1 crystallographic structure (1DE8) and the thermal experimental method. N/A = not available. Once = observed a single time. APE1 sequence entries reported above for computational analyses were identical and corresponded to the wild-type enzyme.